WASHINGTON - A neo-Nazi leader accused of plotting to attack Baltimore's power grid has been found guilty of conspiring to damage an energy facility, the U.S. Justice Department said on Tuesday.

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra (fo ...

At one time, and because of the risk management challenges involved, listed options trading was mostly done by professionals and market makers with limited public participation. Today, you can ...

Companies that are decreasing efficiency in utilisation of Shareholders funds ...